Format

Send to

Choose Destination
Immunity. 2010 Aug 27;33(2):279-88. doi: 10.1016/j.immuni.2010.08.010.

Interleukin-23 drives intestinal inflammation through direct activity on T cells.

Author information

1
Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, England, UK.

Erratum in

  • Immunity. 2011 Mar 25;34(3):448.

Abstract

Mutations in the IL23R gene are linked to inflammatory bowel disease susceptibility. Experimental models have shown that interleukin-23 (IL-23) orchestrates innate and T cell-dependent colitis; however, the cell populations it acts on to induce intestinal immune pathology are unknown. Here, using Il23r(-/-) T cells, we demonstrated that T cell reactivity to IL-23 was critical for development of intestinal pathology, but not for systemic inflammation. Through direct signaling into T cells, IL-23 drove intestinal T cell proliferation, promoted intestinal Th17 cell accumulation, and enhanced the emergence of an IL-17A(+)IFN-gamma(+) population of T cells. Furthermore, IL-23R signaling in intestinal T cells suppressed the differentiation of Foxp3(+) cells and T cell IL-10 production. Although Il23r(-/-) T cells displayed unimpaired Th1 cell differentiation, these cells showed impaired proliferation and failed to accumulate in the intestine. Together, these results highlight the multiple functions of IL-23 signaling in T cells that contribute to its colitogenic activity.

PMID:
20732640
PMCID:
PMC3078329
DOI:
10.1016/j.immuni.2010.08.010
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center